Literature DB >> 6809442

[The effect of anti-arrhythmic drugs on myocardial function (author's transl)].

H A Wester, N Mouselimis.   

Abstract

In a randomized study the influence of anti-arrhythmic drugs on left ventricular myocardial function was tested. Propafenon, mexiletine, tocainide, disopyramide or placebo were given over seven days on top of basic treatment with digitalis, diuretics and nitrates. Propafenon, mexiletine, tocainide and disopyramide had negative inotropic effects of 16, 17, 19 to maximally 30%, respectively. Echocardiography was especially suitable for serial assessment of left ventricular failure. Propafenon, mexiletine and tocainide are the anti-arrhythmic drugs of choice in the treatment of cardiac arrhythmias. However, the at times marked decrease in contractility must be taken into account when the decision is made whether a given arrhythmia requires treatment or not.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809442     DOI: 10.1055/s-2008-1070112

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

Review 1.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

2.  Long term inotropic effects of flecainide and propafenone.

Authors:  E Henze; J Roth; W Haerer; W E Adam; M Stauch
Journal:  Eur J Nucl Med       Date:  1988

3.  Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).

Authors:  J Thormann; W Kramer; P Kremer; M Schlepper
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.